ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
Genital swelling | 21.10.01.010 | 0.001737% | | Not Available |
Oropharyngeal pain | 22.02.05.022; 07.05.05.004 | - | - | |
Acute kidney injury | 20.01.03.016 | - | - | |
H1N1 influenza | 22.07.02.007; 11.05.03.002 | 0.000302% | | Not Available |
Posterior reversible encephalopathy syndrome | 17.13.02.007 | - | - | |
Drug-induced liver injury | 12.03.01.044; 09.01.07.023 | - | - | Not Available |
Lacrimal structural disorder | 06.06.04.013 | - | - | Not Available |
Drug reaction with eosinophilia and systemic symptoms | 23.03.05.005; 10.01.01.021 | - | - | Not Available |
Pneumocystis jirovecii pneumonia | 22.07.08.009; 11.03.07.005 | - | - | Not Available |
Candida infection | 11.03.03.021 | - | - | |
Sinus node dysfunction | 02.03.03.017 | - | - | |
Multiple organ dysfunction syndrome | 08.01.03.057 | 0.001208% | | |
Liver function test increased | 13.03.01.044 | - | - | Not Available |
Abdominal mass | 07.01.01.003 | 0.000302% | | Not Available |
Adenocarcinoma of colon | 16.13.01.010; 07.21.01.008 | 0.001158% | | Not Available |
Brain neoplasm malignant | 16.30.04.002; 17.20.04.002 | 0.001812% | | Not Available |
Ewing's sarcoma | 15.09.03.015; 16.29.03.004 | 0.000302% | | Not Available |
Full blood count decreased | 13.01.07.004 | 0.023739% | | Not Available |
Leprosy | 11.04.03.001 | 0.002895% | | Not Available |
Medulloblastoma | 17.20.02.006; 16.30.02.006 | 0.000302% | | Not Available |
Meningitis tuberculous | 17.06.10.005; 11.04.01.012 | 0.000302% | | Not Available |
Monoclonal immunoglobulin present | 13.06.05.013 | 0.001158% | | Not Available |
Clostridium difficile infection | 11.02.02.009 | 0.004053% | | Not Available |
Hepatic infection | 11.01.18.008; 09.01.08.014 | 0.001158% | | |
Gastric infection | 11.01.07.008; 07.19.03.003 | 0.001158% | | Not Available |
Ovarian epithelial cancer | 21.11.01.017; 16.12.04.006 | 0.000302% | | Not Available |
Abdominal wall haematoma | 24.07.02.039; 07.16.05.005 | 0.001158% | | Not Available |
Apparent death | 08.01.03.062 | 0.001158% | | Not Available |
Type 2 lepra reaction | 24.05.02.026; 11.04.03.004; 23.07.02.006; 10.01.03.048 | 0.001158% | | Not Available |
Human chorionic gonadotropin increased | 13.10.05.024 | 0.016791% | | Not Available |